LARIMAR THERAPEUTICS, INC. (LRMR) Net income 2016–2025
LARIMAR THERAPEUTICS, INC. (LRMR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$165.7MFY2025 · since FY2016: -$57.9M → -$165.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$165.7M | -105.5% |
| FY2024 | -$80.6M | -118.1% |
| FY2023 | -$36.9M | -4.5% |
| FY2022 | -$35.4M | +30.2% |
| FY2021 | -$50.6M | -19.2% |
| FY2020 | -$42.5M | -83.7% |
| FY2019 | -$23.1M | +62.3% |
| FY2018 | -$61.4M | -18.0% |
| FY2017 | -$52.0M | +10.1% |
| FY2016 | -$57.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LRMR financial trends
LRMR RevenueLRMR Net marginLRMR Gross profitLRMR Gross marginLRMR Operating incomeLRMR Operating marginLRMR Operating cash flowLRMR Free cash flowLRMR Capital expendituresLRMR Return on equityLRMR Stock buybacksLRMR Dividends paidLRMR Total assetsLRMR Total liabilitiesLRMR Shareholders’ equityLRMR overview →